Alliance for Pandemic Preparedness

January 25, 2021

NERVTAG Note on B.1.1.7 Severity



Keywords (Tags): ,

[Report, not peer-reviewed] The UK New and Emerging Respiratory Virus Advisory Group (NERVTAG) states the B.1.1.7 SARS-CoV-2 variant has quickly become dominant in the UK, and that there is a possibility that infection with this variant is associated with increased risk of death compared to previous strains. NERVTAG cites evidence of increased case fatality from several independent UK studies of samples with s-gene target failure, a proxy for the B.1.1.7 variant. The COVID Clinical Information Network has not found evidence of increased hospital case fatality with this variant.

Horby et al. (Jan 18, 2021). NERVTAG Note on B.1.1.7 Severity.